Kiran Mazumdar-Shaw Advocates for Innovative Changes in the Biotech Sector at Global Bio-India 2024
Kiran Mazumdar-Shaw Calls for Innovation in the Biotech Sector
During the Global Bio-India 2024 event, Biocon Chairperson Kiran Mazumdar-Shaw urged for significant investments in research and development (R&D) to enhance the innovation landscape of India's biotech sector. She posited that India, as the world's leading exporter of generics and a major vaccine producer, should begin emphasizing value generation through innovation to ascend in the global pharmaceutical arena.
Investment and Initiatives for the Future
Mazumdar-Shaw revealed that India currently ranks 14th in terms of value in the global pharmaceutical industry, stressing that without ample R&D investment and an intellectual property-focused culture, capturing increased value will remain challenging. The VIGYAN Dhara initiative, with an ambitious outlay of Rs 10,000 crore, aims to bolster basic research and critical technologies.
In her speech, she recognized India's extraordinary potential to become a leading hub for bio-innovation, citing the country's remarkable scientific talent, technological advancements, and entrepreneurial vigor.
The Evolving Biotech Landscape
Biotechnology has rapidly evolved, influencing diverse sectors from medicine and agriculture to environmental conservation. Mazumdar-Shaw articulated how emerging technologies such as CRISPR are revolutionizing healthcare, potentially paving the way for curing genetic disorders like cystic fibrosis and muscular dystrophy.
Global Food Security and the Biotech Role
- Advocated for biotechnology as a solution to global food security challenges.
- Highlighted India’s role as the third-largest medicine manufacturer.
- Stressed the significance of CRISPR technologies in modern biotech applications.
As India continues to enhance its capabilities in the biopharmaceutical sector, the call for innovation could redefine the landscape of healthcare and biotechnology. The future aligns with her vision of utilizing these advancements to secure a healthier world.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.